Table S3.
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
Age (years) | 0.747 (0.459 to 1.215) | 0.240 | ||
Gender | 1.378 (0.845 to 2.249) | 0.199 | ||
Tumor location | 1.084 (0.927 to 1.269) | 0.311 | ||
Tumor size | ||||
<5 cm | 0.611 (0.373 to 1.002) | 0.051 | ||
≥5 cm | 1.000 | |||
TNM stage | ||||
I | 0.098 (0.032 to 0.294) | <0.001a | 0.111 (0.036 to 0.339) | <0.001a |
II | 0.204 (0.105 to 0.398) | <0.001a | 0.218 (0.111 to 0.426) | <0.001a |
III | 0.376 (0.200 to 0.710) | 0.003a | 0.390 (0.206 to 0.737) | 0.004a |
IV | 1.000 | 1.000 | ||
APOC1 expression | ||||
High | 1.803(1.101 to 2.955) | 0.019a | 1.450 (0.877 to 2.396) | 0.147 |
Low | 1.000 | 1.000 |
Notes: The TNM staging system is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N) and the presence of metastasis (M).a Statistically significant.